Bectas Therapeutics

Houston, United States

Bectas Therapeutics is a biotech company that develops monoclonal antibody therapies for cancer.

$5.5M raised

Oct 2024

Seed

Biopharma Biotechnology Health Care Wellness

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Bectas Therapeutics

How much funding has Bectas Therapeutics raised?

Bectas Therapeutics has raised $5.5M in total funding. The most recent round was Seed. The last funding was announced in October 2024.

Where is Bectas Therapeutics headquartered?

Bectas Therapeutics is headquartered in Houston, United States.

What does Bectas Therapeutics do?

Bectas Therapeutics is a biotech company that develops monoclonal antibody therapies for cancer.

What stage is Bectas Therapeutics at?

Bectas Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 9, 2024.

MLA

"Bectas Therapeutics — Funding & Investors." VCBacked, October 9, 2024, https://www.vcbacked.co/company/bectas-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Bectas Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/bectas-therapeutics

Wikipedia (cite web)

{{cite web |title=Bectas Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/bectas-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 9, 2024.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.